Botanical species · safety record

Clerodendrum infortunatum

The EFSA Compendium of Botanicals holds 25 constituent measurements and 1 genotoxicity assay for Clerodendrum infortunatum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Clerodendrum infortunatum L.

25Constituent measurements
1Safety records
8Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Alkaloids5
  • Saponins4
  • Tannins4
  • Acacetin 7-o-alpha-l-rhamnopyranoside2
  • Clerodane-type diterpenes2
  • Myrcene2
  • Sterols, total2
  • Benzofuran1
  • Benzoquinones1
  • Hydroxymethylfurfural1

Plant parts

  • Leaves16
  • Roots and other underground parts5
  • Aerial part of plants2
  • Flower2

Preparations

  • Solvent extraction14
  • Essential oil1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Acacetin 7-o-alpha-l-rhamnopyranosideRoots and other underground partsUnspecifiedResolve DOI
Acacetin 7-o-alpha-l-rhamnopyranosideFlowerUnspecifiedResolve DOI
AlkaloidsLeavesUnspecifiedResolve DOI
Clerodane-type diterpenesAerial part of plantsUnspecifiedResolve DOI
MyrceneLeavesUnspecifiedResolve DOI
MyrceneRoots and other underground partsUnspecifiedResolve DOI
SaponinsLeavesUnspecifiedResolve DOI
Sterols, totalAerial part of plantsUnspecifiedResolve DOI
Sterols, totalLeavesUnspecifiedResolve DOI
TanninsLeavesUnspecifiedResolve DOI
AlkaloidsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
AlkaloidsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
AlkaloidsRoots and other underground partsSolvent extractionPhytochemical screeningNo resolvable identifier
AlkaloidsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
BenzofuranLeavesSolvent extraction3.52 PercentGC-MSNo resolvable identifier
BenzoquinonesFlowerEssential oil2.03 PercentGC-MSNo resolvable identifier
Clerodane-type diterpenesLeavesSolvent extractionNo resolvable identifier
HydroxymethylfurfuralLeavesSolvent extraction7.11 PercentGC-MSNo resolvable identifier
QuinonesLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
SaponinsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
SaponinsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
SaponinsRoots and other underground partsSolvent extractionPhytochemical screeningNo resolvable identifier
TanninsRoots and other underground partsSolvent extractionPhytochemical screeningNo resolvable identifier
TanninsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
TanninsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
Positivemicronucleus assayHouse mouse (as animal)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Nandi, Suranjana., Lyndem, Larisha Mawkhlieng. Clerodendrum viscosum: traditional uses, pharmacological activities and phytochemical constituents . Natural product research, 2016, vol. 30, no. 5, p. 497-506. DOI
  2. Ray, S., Kundu, L. M., Goswami, S., Roy, G. C., Chatterjee, S., Dutta, S., Chaudhuri, A., Chakrabarti, C. S. Metaphase arrest and delay in cell cycle kinetics of root apical meristems and mouse bone marrow cells treated with leaf aqueous extract of Clerodendrum viscosum Vent. Cell proliferation, 2013, vol. 46, no. 1, p. 109-117.
  3. Azad, A. K., Wan Azizi, W. S., Syafiq, T. M. F., Mahmood, S., Almoustafa, H. A., Labu, Z. K. Isolation, characterization and cytotoxic effect exploration of methanolic extract of local medicinal plant clerodendrumn viscosum vent. Australian journal of basic and applied sciences, 2013, vol. 7, no. 4, p. 641-647.
  4. Kale, Anand., Maniyar, Yasmeen A. Evaluation of anti-inflammatory activity of ethanolic extract of clerodendrum infortunatum Linn-in rats. World journal of pharmaceutical research, 2015, vol. 4, no. 9, p. 942-952.
  5. Sultana, Nasim., Akanda, Shafiqul Islam., Bhuiyan, Rauf Ahmed., Bagum, Shameem Ara., Kazi, M. Azizul Islam., Sharkar, Abdul Mannan. A neo-clerodane diterpenoid from Clerodendrum viscosum leaves. Bangladesh journal of scientific and industrial research, 2005, vol. 40(3-4), p. 337-341.
  6. Florence, A.R., Joselin, J., Jeeva, S. Intra-specific variation of bioactive principles in select members of the genus Clerodendrum L. Journal of chemical and pharmaceutical research, 2012, vol. 4, no. 11, p. 4908-4914.
  7. Panda, Pritipadma., Rath, Meera., Pal, Abhisek., Sharma, Tripti., Das, Debajyoti. GC-MS analysis of bioactive compounds in the methanol extract of Clerodendrum viscosum leaves. Pharmacognosy research, 2015, vol. 7, no. 1), 110-11, p. 4 pp.
  8. Islam, Rafiquel., Rahman, Atiqur. A GC-MS study: Identification of the essential oil compositions of Clerodendrum viscosum vent flower. Journal of essential oil-bearing plants, 2015, vol. 18, no. 5, p. 1271-1274.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue